| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 61,070 | 56,963 | 50,404 | 61,799 | | Cost of Revenue | 52,023 | 55,787 | 71,444 | 66,075 | | | Gross Profit | 9,047 | 1,176 | (21,040) | (4,276) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,126 | 4,016 | 4,368 | 4,733 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,921 | (2,840) | (25,408) | (9,009) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 111 | 17 | 65 | 86 | | Earnings Before Interest And Taxes | 5,032 | (2,823) | (25,343) | (8,923) | | Interest Expense | 157 | 147 | 189 | 148 | | Income Before Tax | 4,875 | (2,970) | (25,532) | (9,071) | | Income Tax Expense | 2,097 | (1,233) | (9,150) | (3,472) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,778 | (1,737) | (16,382) | (5,599) | | | Non-recurring Events | | Discontinued Operations | (1,085) | (12) | (13) | (36) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,693 | (1,749) | (16,395) | (5,635) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,693 | ($1,749) | ($16,395) | ($5,635) |
|
0.51% Nasdaq 
0.08 (0.62%) 
Income Statement
